GE HealthCare raises 2026 outlook after positive Q3
In Q3, GE HealthCare reported notable growth in PDx, a segment it moved to strengthen earlier this month with the $945m acquisition of SOFIE Biosciences.
In Q3, GE HealthCare reported notable growth in PDx, a segment it moved to strengthen earlier this month with the $945m acquisition of SOFIE Biosciences.
The British government will now change up AI-enabled medical device regulation to encourage innovation with the appropriate guardrails.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
Australia starts investigation into OpenAI Medicare breach
Industry partnership will determine the success of the transition to low-GWP pMDIs
UK government champions healthtech through new NHS access programme